PEAK6 Investments’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

PEAK6 Investments’s Portfolio NKGNW Stock Details NKGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-11,039	Closed	-$892	–	4876
2023 Q4	$892	Hold	11,039	–	–	﹤0.01%	4065
2023 Q3	$4.36K	Hold	11,039	–	–	﹤0.01%	3866
2023 Q2	$2.1K	Hold	11,039	–	–	﹤0.01%	3728
2023 Q1	$1.55K	Hold	11,039	–	–	﹤0.01%	4078
2022 Q4	$938	Hold	11,039	–	–	﹤0.01%	4241
2022 Q3	$1K	Sell	11,039 -11,039	-50%	-$1.9K	﹤0.01%	4808
2022 Q2	$5.1K	Buy	+22,078	New	+$8.74K	﹤0.01%	5888

Other funds holding NKGNW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

EAM

Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

PEAK6 Investments's NKGNW Position: Q1 2024 in Review

PEAK6 Investments sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q1 2024, closing a stake of 11,039 shares — an estimated $892 sold.

PEAK6 Investments first reported a position in NKGNW in Q2 2022 and held it in 7 quarters. The position peaked at $5.1K in Q2 2022. 30 funds tracked by Wall St. Rank hold NKGNW as of Q1 2024.

PEAK6 Investments reported no remaining NKGen Biotech, Inc. Warrants position as of Q1 2024 after selling out during the quarter.
PEAK6 Investments sold 11,039 NKGen Biotech, Inc. Warrants shares in Q1 2024, an estimated $892.
PEAK6 Investments first reported a position in NKGen Biotech, Inc. Warrants in Q2 2022 and held it in 7 quarters.
PEAK6 Investments's NKGen Biotech, Inc. Warrants position peaked at $5.1K in Q2 2022.
30 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q1 2024.

Based on PEAK6 Investments's 13F filing for Q1 2024, filed 14 May 2024.